Wang, Huihao
Yuan, Weian
Yu, Zhongxiang
Wang, Xiang
Zhao, Xinxin
Deng, Zhen
Yang, Guangyue
Chen, Weinan
Shen, Zhibi
Zhan, Hongsheng
Funding for this research was provided by:
Clinical Research Plan of SHDC (SHDC2020CR1051B)
Major Research Plan (81973871)
Young Scientists Fund (81804114)
Article History
Received: 18 April 2021
Accepted: 24 March 2022
First Online: 23 April 2022
Declarations
:
: Written informed consent will be obtained from all participants before enrolment in the study. The study design and procedures were approved by the IRB of Shuguang Hospital Affiliated to Shanghai University of TCM (Approval Number: 2020-850-57-01), and protocol version 2.1/20210120 is currently active. During the screening visit, a physician explains all study procedures, and written informed consent is only given after participants had adequate time to ask questions. Each subject should voluntarily sign an informed consent form before testing begins in the study. The informed consent documents and the related files can be accessed in ExternalRef removed (identifier ChiCTR2000036515) if desired.
: Authorship to the trial publications will be determined in accordance with the ICMJE recommendations.
: The authors declare that they have no competing interests.